Raksha Indorkar1, Raymond Y Kwong2, Simone Romano3, Brent E White1, Richard C Chia1, Michael Trybula1, Kaleigh Evans1, Chetan Shenoy4, Afshin Farzaneh-Far5. 1. Division of Cardiology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois. 2. Division of Cardiology, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts. 3. Department of Medicine, University of Verona, Verona, Italy. 4. Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, Minnesota. 5. Division of Cardiology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois; Division of Cardiology, Department of Medicine, Duke University, Durham, North Carolina. Electronic address: afshin@uic.edu.
Abstract
OBJECTIVES: The aim of this study was to evaluate the incremental prognostic value of global coronary flow reserve (CFR) in patients with known or suspected coronary artery disease who were undergoing stress cardiac magnetic resonance (CMR) imaging. BACKGROUND: Coronary microvascular dysfunction results in impaired global CFR and is implicated in the development of both atherosclerosis and heart failure. Although noninvasive assessment of CFR with positron emission tomography provides independent prognostic information, the incremental prognostic value of CMR-derived CFR remains unclear. METHODS: Consecutive patients undergoing stress perfusion CMR were prospectively enrolled (n = 507). Coronary sinus flow was measured using phase-contrast imaging at baseline (pre) and immediately after stress (peak) perfusion. CFR was calculated as the ratio of peak to pre-flow. Patients were followed for major adverse cardiac events (MACE): death, nonfatal myocardial infarction, heart failure hospitalization, sustained ventricular tachycardia, and late revascularization. Cox proportional hazards regression modeling was used to examine the association between CFR and MACE. The incremental prognostic value of CFR was assessed in nested models. RESULTS: Over a median follow-up of 2.1 years, 80 patients experienced MACE. By Kaplan-Meier analysis, the risk of MACE was significantly higher in patients with CFR lower than the median (2.2) (log-rank p < 0.001); this remained significant after adjustment for the presence of ischemia and late gadolinium enhancement (LGE) (log-rank p < 0.001). CFR was significantly associated with the risk of MACE after adjustment for clinical and imaging risk factors, including ischemia extent, ejection fraction, and LGE size (hazard ratio: 1.238; p = 0.018). Addition of CFR in this model resulted in significant improvement in the C-index (from 0.70 to 0.75; p = 0.0087) and a continuous net reclassification improvement of 0.198 (95% confidence interval: 0.120 to 0.288). CONCLUSIONS: CMR-derived CFR is an independent predictor of MACE in patients with known or suspected coronary artery disease, incremental to common clinical and CMR risk factors. These findings suggest a role for CMR-derived CFR in identifying patients at risk of adverse events following stress CMR, even in the absence of ischemia and LGE.
OBJECTIVES: The aim of this study was to evaluate the incremental prognostic value of global coronary flow reserve (CFR) in patients with known or suspected coronary artery disease who were undergoing stress cardiac magnetic resonance (CMR) imaging. BACKGROUND: Coronary microvascular dysfunction results in impaired global CFR and is implicated in the development of both atherosclerosis and heart failure. Although noninvasive assessment of CFR with positron emission tomography provides independent prognostic information, the incremental prognostic value of CMR-derived CFR remains unclear. METHODS: Consecutive patients undergoing stress perfusion CMR were prospectively enrolled (n = 507). Coronary sinus flow was measured using phase-contrast imaging at baseline (pre) and immediately after stress (peak) perfusion. CFR was calculated as the ratio of peak to pre-flow. Patients were followed for major adverse cardiac events (MACE): death, nonfatal myocardial infarction, heart failure hospitalization, sustained ventricular tachycardia, and late revascularization. Cox proportional hazards regression modeling was used to examine the association between CFR and MACE. The incremental prognostic value of CFR was assessed in nested models. RESULTS: Over a median follow-up of 2.1 years, 80 patients experienced MACE. By Kaplan-Meier analysis, the risk of MACE was significantly higher in patients with CFR lower than the median (2.2) (log-rank p < 0.001); this remained significant after adjustment for the presence of ischemia and late gadolinium enhancement (LGE) (log-rank p < 0.001). CFR was significantly associated with the risk of MACE after adjustment for clinical and imaging risk factors, including ischemia extent, ejection fraction, and LGE size (hazard ratio: 1.238; p = 0.018). Addition of CFR in this model resulted in significant improvement in the C-index (from 0.70 to 0.75; p = 0.0087) and a continuous net reclassification improvement of 0.198 (95% confidence interval: 0.120 to 0.288). CONCLUSIONS: CMR-derived CFR is an independent predictor of MACE in patients with known or suspected coronary artery disease, incremental to common clinical and CMR risk factors. These findings suggest a role for CMR-derived CFR in identifying patients at risk of adverse events following stress CMR, even in the absence of ischemia and LGE.
Authors: Simone Romano; Robert M Judd; Raymond J Kim; John F Heitner; Dipan J Shah; Chetan Shenoy; Kaleigh Evans; Benjamin Romer; Pablo Salazar; Afshin Farzaneh-Far Journal: JACC Cardiovasc Imaging Date: 2019-11-11
Authors: Harmony R Reynolds; C Noel Bairey Merz; Colin Berry; Rohit Samuel; Jacqueline Saw; Nathaniel R Smilowitz; Ana Carolina do A H de Souza; Robert Sykes; Viviany R Taqueti; Janet Wei Journal: Circ Res Date: 2022-02-17 Impact factor: 17.367
Authors: Rajat Kalra; Shray Malik; Ko-Hsuan Amy Chen; Fredrick Ogugua; Pal Satyajit Singh Athwal; Andrew C Elton; Pratik S Velangi; Mohamed F Ismail; Sanya Chhikara; Jeremy S Markowitz; Prabhjot S Nijjar; Lisa von Wald; Henri Roukoz; Maneesh Bhargava; David Perlman; Chetan Shenoy Journal: Circ Arrhythm Electrophysiol Date: 2021-09-01
Authors: Sebastian Kelle; Andreas Schuster; Sören J Backhaus; Georg Metschies; Marcus Billing; Jonas Schmidt-Rimpler; Johannes T Kowallick; Roman J Gertz; Tomas Lapinskas; Elisabeth Pieske-Kraigher; Burkert Pieske; Joachim Lotz; Boris Bigalke; Shelby Kutty; Gerd Hasenfuß Journal: J Cardiovasc Magn Reson Date: 2021-05-17 Impact factor: 5.364
Authors: Simone Romano; Davide Dell'atti; Robert M Judd; Raymond J Kim; Jonathan W Weinsaft; Jiwon Kim; John F Heitner; Rebecca T Hahn; Afshin Farzaneh-Far Journal: JACC Cardiovasc Imaging Date: 2021-04-14
Authors: Ashley S Manchanda; Alan C Kwan; Mariko Ishimori; Louise E J Thomson; Debiao Li; Daniel S Berman; C Noel Bairey Merz; Caroline Jefferies; Janet Wei Journal: Front Cardiovasc Med Date: 2022-04-15
Authors: Patricia F Rodriguez Lozano; Elona Rrapo Kaso; Jamieson M Bourque; Mohamed Morsy; Angela M Taylor; Todd C Villines; Christopher M Kramer; Michael Salerno Journal: JACC Cardiovasc Imaging Date: 2022-03-16